Five pharmaceutical stocks to keep an eye on today!

Five pharmaceutical stocks to keep an eye on today!

by 5paisa Research Team Last Updated: 2022-02-24T12:09:49+05:30

While BSE Sensex had a steep fall of 2.92%, BSE Healthcare has lost a 2.05% in the morning fall.

These are the 5 stocks from the Pharma sector that are in focus today.

Piramal Enterprises: The Board to consider and approve the issue of NCDs up to Rs 100 crore along with an option to retain over-subscription up to Rs 400 crore on a private placement basis on 28 February. At 10 AM, shares of the company was trading 5% down at Rs 1,984.40.

Cadila Healthcare: Zydus has received final approval from the USFDA to market Dapagliflozin Tablets in the strengths of 5 mg and 10 mg. Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Today it is trading, 3.5% down.

Sun Pharmaceuticals: The firm will buy anti-acne brand Alchemee for $90 million. Alchemee is an omni-channel brand platform that creates and markets clinically-proven, dermatologist-tested treatments paired with gentle skincare to provide better skin for life. Alchemee's brand portfolio, anchored by the iconic brand Proactiv, has a 25-year history of being the trusted acnefighter delivering effective, reliable results. Today, it is trading 1.9% down.

Marksans Pharma: Marksans Pharma announces that UK MHRA has granted Market Authorisation to the Company's wholly owned subsidiary Bell Sons & Co. (Druggists) Limited for Bells Healthcare All in One Oral Solution. Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs. Today, share is trading 3.61% down.

Dr Reddy’s Laboratories: The Sistema Group company, Binnopharm Group, one of the leading pharmaceutical production companies in Russia via its affiliate Joint Stock Company ‘Alium’, and Dr. Reddy's Laboratories announced the signing of a deal that will allow Binnopharm Group to acquire anti-bacterial medicines under the Ciprolet and Levolet brands from Dr Reddy’s in Russia, Uzbekistan and Belarus. Today, share is trading down by 2.5%.


Also read: Four factors weighing on markets as Nifty, Sensex plunge 3% to enter correction zone

Start Investing in 5 mins*

Get Benefits worth 2100* | Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Open Free Demat Account

& get benefits worth 2100*

Resend OTP
Please Enter OTP
  • Have Promo code?
  • Use code ACT2100
Enter Promo code

By proceeding, you agree to the T&C.

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number